Diagnostics
-
How Genome Sequencing Can Broaden the Scope of Newborn Screening
Standard newborn screening can detect dozens of inherited diseases, but genomics technology enables testing for hundreds of them. A North Carolina program evaluating the feasibility of bringing genomics to newborn screening is expanding with an initial goal of testing 5,000 babies in the next year.
-
Quest Expands in Cancer Testing With $300M Haystack Oncology Acquisition
Quest Diagnostics is acquiring liquid biopsy company Haystack Oncology. The startup’s technology is used for identifying cancer patients who need adjuvant therapy.
-
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
-
StartUPDATES: New Developments from Healthcare Startups
Check out news from BioMEMS Diagnostics, Rx Redefined, Ferrum Health and Avanlee Care.
-
More Talent and Technology Offer Solutions for Medical Laboratory Staffing Shortages
Process improvement and advanced technology can also help relieve the staffing burden that medical laboratories are facing.
-
Thermo Fisher bets big on blood cancer, immune diagnostics with $2.6B Binding Site buyout
Thermo Fisher Scientific’s acquisition of The Binding Site brings a company that specializes in diagnostic tests for blood cancers and immune system disorders. It’s Thermo Fisher’s biggest acquisition since its 2021 buyout of contract research organization PPD.
-
Report: Cancer deaths are down but pancreatic cancer is growing, racial disparities persist
Targeted drugs and immunotherapies are among the advances that contribute to declines in incidence and deaths from non-small cell lung cancer, according to the Annual Report to the Nation on the Status of Cancer. But the trends are on the rise for some other cancers and racial disparities persist, highlighting the need to better understand these differences.
-
Owkin’s AI solutions for breast and colorectal cancer receive European approval
The breast cancer solution will help determine which patients would benefit from targeted therapies and which patients could avoid chemotherapy. Meanwhile, the colorectal solution will be able to match patients with the most effective treatment sooner.
-
MedCity Influencers, Diagnostics
A Covid-19 reflection: Incorporating what we’ve learned for improved preparedness
Beyond preparedness policies, we need to think forward to policies that rapidly identify the spread of zoonotic disease to prevent or minimize the impact.
-
MedCity Influencers, Diagnostics
Robotics and automation are the future of healthcare
Advanced technologies, such as AI-guided robotics and automation, offer a potential solution to the provider shortage by freeing healthcare professionals from repetitive and time-consuming tasks and allow clinicians to focus on tasks that require a specialized touch.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
StartUPDATES: New developments from healthcare startups
Check out new developments from BioMEMS Diagnostics, Neuroflow, Druglike, Health Note, and Rhinostics.
-
StartUPDATES: New developments from healthcare startups
Check out news from Equiva, Canvas Medical, Particle Health, Fold Health, and Nucleus Genomics.
-
MedCity Influencers, Diagnostics, Health Tech
How vocal biomarkers are becoming a necessary tool for remote patient monitoring
With the information contained in a simple 30-second voice sample, providers can help patients get ahead of future health issues and prescribe or adjust treatment plans as needed.
-
Devices & Diagnostics, Health Services
Two firms team up to facilitate at-home screenings to prevent blindness
MedArrive providers will use Spect’s artificial intelligence-enabled telemedicine platform to screen patients at home for eye diseases such as diabetic retinopathy, glaucoma and age-related macular degeneration.
-
Diagnostic startups: Time is running out to apply to INVEST Pitch Perfect
The point of care diagnostics and testing market has climbed dramatically with the rise of the Covid-19 public health crisis. We’re seeking applications for diagnostics startups who would like to take part in INVEST Pitch Perfect Diagnostics 2.0 track at the conference, scheduled to take place March 28-30 in Chicago.
-
Why Medicare does not cover rapid at-home Covid tests
It turns out that the laws governing traditional Medicare don’t provide for coverage of self-administered diagnostic tests. Medicare patients are left to seek free tests other ways, including through the administration’s new website, covidtests.gov, and at community centers.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
